While EG5 is upregulated in cancer cells, microtubule-targeting chemotherapeutic agents, such as paclitaxel simultaneously upregulate Eg5 in healthy tissues, contributing to side effects, including CIPN, and possibly gastrointestinal distress and alopecia (Fig. 6c). The gene discussed is KIF11; the disease is alopecia.